Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Abstract Aims Allogeneic stem cell therapy is more logistically suitable compared with autologous cell therapy for large‐scale patient treatment. We aim to investigate the clinical safety and efficacy profile of the allogeneic adipose tissue derived mesenchymal stromal cell product (CSCC_ASC) as an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abbas Ali Qayyum, Sabina Frljak, Morten Juhl, Gregor Poglajen, Gregor Zemljičl, Andraz Cerar, Thomas Litman, Annette Ekblond, Mandana Haack‐Sørensen, Lisbeth Drozd Højgaard, Jens Kastrup, Bojan Vrtovec
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	ESC Heart Failure
Subjects:	Adipose tissue derived mesenchymal stromal cells Allogeneic therapy Clinical trial Heart failure Stem cells
Online Access:	https://doi.org/10.1002/ehf2.14925
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation
by: Abbas Ali Qayyum, MD, MSc, PhD, et al.
Published: (2025-05-01)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
by: Sabina Frljak, et al.
Published: (2022-03-01)

GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
by: Mandana Haack-Sørensen, et al.
Published: (2022-01-01)

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
by: Gregor Poglajen, et al.
Published: (2018-01-01)

Salvage treatment of steroid-refractory acute GVHD with the off-the-shelf product of human umbilical cord mesenchymal stromal cells: a multicenter, open label, phase Ib/IIa trial
by: Yanmin Zhao, et al.
Published: (2025-07-01)

Blood Serum from Patients with Acute Leukemia Inhibits the Growth of Bone Marrow Multipotent Mesenchymal Stromal Cells
by: Nataliya Petinati, et al.
Published: (2025-05-01)

POSITIVE RESULTS OF TRANSPLANTATION OF MULTI-COMPONENT COMPOSITE MATERIAL CONTAINING ALLOGENEIC MESENCHYMAL STEM CELLS AFTER CYSTECTOMY IN A RABBIT
by: N. V. Orlovа, et al.
Published: (2017-06-01)

ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumors
by: Jean Pierre Bikorimana, et al.
Published: (2025-07-01)

Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How To Account for Histocompatibility and Disease Specificity of EV Treatments
by: Philip W. Askenase
Published: (2025-05-01)

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial
by: Ke Zhao, et al.
Published: (2025-07-01)

THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
by: V. A. Lyashenko, et al.
Published: (2014-07-01)

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center
by: Mathias Castonguay, et al.
Published: (2025-05-01)

Mesenchymal stromal cells from people with osteoporosis are fewer, and defective in both osteogenic and adipogenic capacity
by: Féaron C. Cassidy, et al.
Published: (2024-06-01)

BMP-2-Driven Osteogenesis: A Comparative Analysis of Porcine BMSCs and ASCs and the Role of TGF-β and FGF Signaling
by: Roman Taday, et al.
Published: (2025-05-01)

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
by: Shuxian Zhu, et al.
Published: (2025-01-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction
by: Bjarke Follin, et al.
Published: (2018-01-01)

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis
by: Alexander Biederstädt, et al.
Published: (2025-07-01)

Allogeneic fibroblast sheets prevent pulmonary air leaks caused by rat pleural defects without adhesion to the thoracic wall
by: Hiroaki Shidei, et al.
Published: (2025-03-01)

IFNγ production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritis
by: Mélissa Noack, et al.
Published: (2025-07-01)

Mesenchymal stem cell extracellular vesicle vascularization bioactivity and production yield are responsive to cell culture substrate stiffness
by: Emily H. Powsner, et al.
Published: (2025-05-01)

Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2015-08-01)

EFFECTS OF HUMAN PLATELET LYSATE PREPARATIONS ON THE PROLIFERATION OF BONE MARROW DERIVED MICE MESENCHYMAL STEM CELLS
by: Majid Hameed Mohammed
Published: (2016-08-01)

The prognostic value of posttransplant chimerism
by: A. A. Sipol, et al.
Published: (2022-11-01)

Mixed cultures of allogeneic dendritic cells are phenotypically and functionally stable – a potential for primary cell-based “off the shelf” product generation
by: Urban Švajger, et al.
Published: (2021-07-01)

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
by: saveria capria, et al.
Published: (2012-01-01)

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
by: saveria capria, et al.
Published: (2012-11-01)

Recent advancements in hematopoietic stem cell transplantation in Taiwan
by: Chi-Cheng Li, et al.
Published: (2024-01-01)

Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia
by: Myriam Razgallah Khrouf, et al.
Published: (2017-01-01)

Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
by: Ke Zeng, et al.
Published: (2024-12-01)

VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens
by: Ibel Carri, et al.
Published: (2025-01-01)

STROMAL CELLS OF FAT TISSUE FOR REGENERATIVE SURGERY
by: V. B. Karpuk, et al.
Published: (2019-04-01)

Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
by: Haiqiong Zheng, et al.
Published: (2024-11-01)

Cryopreservation of mesenchymal stem cells derived from dental pulp: a systematic review
by: Sabrina Moreira Paes, et al.
Published: (2021-05-01)

The clinical potential of meniscal progenitor cells
by: Wan-Ting Yan, et al.
Published: (2024-12-01)

Immunomodulatory interactions between mesenchymal stromal/stem cells and immune cells in psoriasis: therapeutic potential and challenges
by: Mohammadreza Dashti, et al.
Published: (2025-05-01)

High impact works on stem cell transplantation in intervertebral disc degeneration
by: Xiaofeng Chen, et al.
Published: (2024-12-01)

Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01)

Retinal progenitor cells (jCell) for retinitis pigmentosa
by: Jing Yang, et al.
Published: (2025-08-01)

Modern Treatments of Bronchial Fistulas
by: I. S. Polyakov, et al.
Published: (2025-05-01)